PT Merck Tbk (MERK.JK)
IDR 3580.0
(0.85%)
IDR 3580.0
(0.85%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 11.19 Billion IDR | 15.06% |
| 2022 | 9.73 Billion IDR | -25.83% |
| 2021 | 13.11 Billion IDR | -12.37% |
| 2020 | 14.97 Billion IDR | 0.0% |
| 2019 | - IDR | 0.0% |
| 2018 | - IDR | 0.0% |
| 2017 | - IDR | 0.0% |
| 2016 | - IDR | 0.0% |
| 2015 | - IDR | 0.0% |
| 2014 | - IDR | 0.0% |
| 2013 | - IDR | 0.0% |
| 2012 | - IDR | 0.0% |
| 2011 | - IDR | 0.0% |
| 2010 | - IDR | 0.0% |
| 2009 | - IDR | 0.0% |
| 2008 | - IDR | 0.0% |
| 2007 | - IDR | 0.0% |
| 2006 | - IDR | 0.0% |
| 2005 | - IDR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q3 | - IDR | 0.0% |
| 2024 Q1 | 14.27 Billion IDR | 0.0% |
| 2024 Q2 | 13.1 Billion IDR | 0.0% |
| 2023 Q3 | 9.96 Billion IDR | -7.14% |
| 2023 Q1 | 8.79 Billion IDR | -9.59% |
| 2023 FY | 11.19 Billion IDR | 15.06% |
| 2023 Q4 | 11.19 Billion IDR | 12.37% |
| 2023 Q2 | 10.72 Billion IDR | 21.95% |
| 2022 FY | 9.73 Billion IDR | -25.83% |
| 2022 Q1 | 11.67 Billion IDR | -11.03% |
| 2022 Q4 | 9.73 Billion IDR | -7.69% |
| 2022 Q2 | 10.91 Billion IDR | -6.52% |
| 2022 Q3 | 10.54 Billion IDR | -3.39% |
| 2021 Q2 | 13.78 Billion IDR | -8.52% |
| 2021 FY | 13.11 Billion IDR | -12.37% |
| 2021 Q4 | 13.11 Billion IDR | -12.59% |
| 2021 Q1 | 15.06 Billion IDR | 0.66% |
| 2021 Q3 | 15 Billion IDR | 8.87% |
| 2020 Q3 | - IDR | 0.0% |
| 2020 Q1 | - IDR | 0.0% |
| 2020 Q2 | - IDR | 0.0% |
| 2020 FY | 14.97 Billion IDR | 0.0% |
| 2020 Q4 | 14.97 Billion IDR | 0.0% |
| 2019 Q2 | - IDR | 0.0% |
| 2019 Q3 | - IDR | 0.0% |
| 2019 Q4 | - IDR | 0.0% |
| 2019 Q1 | - IDR | 0.0% |
| 2019 FY | - IDR | 0.0% |
| 2018 Q2 | - IDR | 0.0% |
| 2018 FY | - IDR | 0.0% |
| 2018 Q4 | - IDR | 0.0% |
| 2018 Q3 | - IDR | 0.0% |
| 2018 Q1 | - IDR | 0.0% |
| 2017 Q2 | - IDR | 0.0% |
| 2017 Q1 | - IDR | 0.0% |
| 2017 FY | - IDR | 0.0% |
| 2017 Q4 | - IDR | 0.0% |
| 2017 Q3 | - IDR | 0.0% |
| 2016 Q3 | - IDR | 0.0% |
| 2016 FY | - IDR | 0.0% |
| 2016 Q4 | - IDR | 0.0% |
| 2016 Q2 | - IDR | 0.0% |
| 2016 Q1 | - IDR | 0.0% |
| 2015 FY | - IDR | 0.0% |
| 2015 Q1 | - IDR | 0.0% |
| 2015 Q2 | - IDR | 0.0% |
| 2015 Q3 | - IDR | 0.0% |
| 2015 Q4 | - IDR | 0.0% |
| 2014 Q3 | - IDR | 0.0% |
| 2014 FY | - IDR | 0.0% |
| 2014 Q2 | - IDR | 0.0% |
| 2014 Q4 | - IDR | 0.0% |
| 2014 Q1 | - IDR | 0.0% |
| 2013 FY | - IDR | 0.0% |
| 2013 Q2 | - IDR | 0.0% |
| 2013 Q1 | - IDR | 0.0% |
| 2013 Q4 | - IDR | 0.0% |
| 2013 Q3 | - IDR | 0.0% |
| 2012 Q1 | - IDR | 0.0% |
| 2012 FY | - IDR | 0.0% |
| 2012 Q4 | - IDR | 0.0% |
| 2012 Q3 | - IDR | 0.0% |
| 2012 Q2 | - IDR | 0.0% |
| 2011 Q4 | - IDR | 0.0% |
| 2011 Q1 | - IDR | 0.0% |
| 2011 FY | - IDR | 0.0% |
| 2010 Q4 | - IDR | 0.0% |
| 2010 FY | - IDR | 0.0% |
| 2010 Q1 | - IDR | 0.0% |
| 2010 Q3 | - IDR | 0.0% |
| 2009 Q4 | - IDR | 0.0% |
| 2009 FY | - IDR | 0.0% |
| 2008 FY | - IDR | 0.0% |
| 2007 FY | - IDR | 0.0% |
| 2006 FY | - IDR | 0.0% |
| 2005 FY | - IDR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| PT Darya-Varia Laboratoria Tbk | 1.04 Billion IDR | -972.638% |
| PT Phapros, Tbk | 162.65 Billion IDR | 93.117% |
| PT Pyridam Farma Tbk | 830.4 Billion IDR | 98.652% |
| PT Industri Jamu dan Farmasi Sido Muncul Tbk | 3.3 Billion IDR | -239.267% |
| PT Tempo Scan Pacific Tbk | 70.73 Billion IDR | 84.171% |